CD4 and neoplasm: Subsequently, type II NKT cells were shown to be sufficient for the suppression of tumor immunity in multiple mouse tumor models, in which CD4+CD25+ regulatory T cells (Tregs) do not play a critical role in the regulation of immunosurveillance (24, 45).